α-Synuclein-synaptosomal membrane interactions Implications for fibrillogenesis

European Journal of Biochemistry

Volumn 271, Issue 15, 2004, Pages 3180-3189

  Jo, Euijung ^a   Darabie, Audrey A ^a   Han, Kyung ^a   Tandon, Anurag ^a,c   Fraser, Paul E ^a,b   McLaurin, JoAnne ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Tanz Neuroscience Building 6   (Canada)

Author keywords

Anisotropy; Electron microscopy; Fibrillogenesis; Fluorescence spectroscopy; Membrane

Indexed keywords

ALPHA SYNUCLEIN; LIPID; MEROCYANINE; MUTANT PROTEIN;

ABSORPTION SPECTROSCOPY; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BINDING AFFINITY; DIMERIZATION; ELECTRON MICROSCOPY; FLUORESCENCE SPECTROSCOPY; LIPID BILAYER; MEMBRANE BINDING; MEMBRANE FLUIDITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; SYNAPTIC MEMBRANE; WILD TYPE;

ALANINE; ALPHA-SYNUCLEIN; ANIMALS; CIRCULAR DICHROISM; DIMERIZATION; FATTY ACIDS; HUMANS; MICROSCOPY, ELECTRON; MUTATION; NERVE TISSUE PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; RATS; SPECTROMETRY, FLUORESCENCE; SURFACE PROPERTIES; SYNAPTIC MEMBRANES; SYNAPTOSOMES; SYNUCLEINS; TYROSINE;

ANIMALIA;

EID: 3242879787     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04250.x     Document Type: Article

References (54)

1. Goedert, M., Jakes, R., Crowther, R.A., Hasegawa, M., Smith, M.J. & Spillantini, M.G. (1998) Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases. Biochem. Soc. Trans. 26, 463-471.
2. Mezey, E., Dehejia, A.M., Harta, G., Tresser, N., Suchy, S.F., Nussbaum, R.L., Brownstein, M.J. & Polymeropoulos, M.H. (1998) Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol. Psychiatry 3, 493-499.
3. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. & Goedert, M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
4. Trojanowski, J.Q. & Lee, V.M. (1998) Aggregation of neurofila-ment and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55, 151-152.
5. Wakabayashi, K., Matsumoto, K., Takayama, K., Yoshimoto, M. & Takahashi, H. (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 239, 45-48.
6. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
7. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. & Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
8. Singelton, A.B., Fairer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) α-Synuclein locus triplication causes Parkinson's Disease. Science 302, 841.
9. Arai, T., Ueda, K., Ikeda, K., Akiyama, H., Haga, C., Kondo, H., Kuroki, N., Niizato, K., Iritani, S. & Tsuchiya, K. (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein Neurosci. Lett. 259, 83-86.
10. Arima, K., Ueda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H. & Kawai, M. (1998) NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. (Berl) 96, 439-444.
11. Spillantini, M.G., Crowther, R.A., Jakes, R., Cairns, N.J., Lantos, P.L. & Goedert, M. (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies Neurosci. Lett. 251, 205-208.
12. Tu, P.H., Galvin, J.E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J.Q. & Lee, V.M. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44, 415-422.
13. Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M. & Takahashi, H. (1998) Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. (Berl) 96, 445-452.
14. Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H. & Takahashi, H. (2000) NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol. (Berl) 99, 14-20.
15. Clayton, D.F. & George, J.M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249-254.
16. Clayton, D.F. & George, J.M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 120-129.
17. Goedert, M. (1997) Familial Parkinson's disease. The awakening of alpha-synuclein. Nature 388, 232-233.
18. Davidson, W.S., Jonas, A., Clayton, D.F. & George, J.M. (1998) Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449.
19. Jo, E., McLaurin, J., Yip, C.M., St. George Hyslop, P. & Fraser, P.E. (2000) α-Synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275, 34328-34334.
20. Uversky, V.N., Lee, H.-J., Li, J., Fink, A.L. & Lee, S.-J. (2001) Stabilization of partially folded conformation during synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276, 43495-43498.
21. Cole, N.B., Murphy, D.D., Grider, T., Rueter, S., Brasaemle, D. & Nussbaum, R.L. (2002) Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein. J. Biol. Chem. 277, 6344-6352.
22. Leng, Y., Chase, T.N. & Bennett, M.C. (2001) Muscarinic receptor stimulation induces translocation of an α-synuclein oligomer from plasma membrane to a light vesicle fraction in cytoplasm. J. Biol. Chem. 276, 28212-28218.
23. Eliezer, D., Kutluay, E., Bussell, R. & Browne, G. (2001) Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061-1073.
24. Perrin, R.J., Woods, W.S., Clayton, D.F. & George, J.M. (2000) Interaction of human-synuclein and parkinson's disease variants with phospholipids. Structural analysis using site-directed muta-genesis. J. Biol. Chem. 275, 34393-34398.
25. Conway, K.A., Lee, S.-J., Rochet, J.-C, Ding, T.T., Williamson, R. E. & Lansbury, P.T. Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl Acad. Sci. USA 97, 571-576.
26. McLean, P.J., Kawamata, H., Ribich, S. & Hyman, B.T. (2000) Membrane association and protein conformation of α-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275, 8812-8816.
27. Jenson, P.H., Nielsen, M.S., Jakes, R., Dotti, G.G. & Goedert, M. (1998) Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273, 26292-26294.
28. Jo, E., Fuller, N., Rand, R.P., St. George-Hyslop, P. & Fraser, P.E. (2002) Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J. Mol. Biol. 315, 799-807.
29. Tandon, A., Bannykh, S., Kowalchyk, J.A., Banerjee, A., Martin, T.F.J. & Balch, W.E. (1998) Differential regulation of exocytosis by calcium and CAPS in semi-intact synaptosomes. Neuron 21, 147-154.
30. Tandon, A., Tan, P.K., Bannykh, S., Banerjee, A. & Balch. W.E. (1998) Neurotransmitter release from semi-intact synaptosomes. Methods 16, 198-203.
31. Bartlett, G.R. (1959) Phospholipid analyses. Biochemistry 342, 466-468.
32. Waschuk, S.A., Elton, E.A., Darabie, A.A., Fraser, P.E. & McLaurin, J. (2001) Cellular membrane composition defines Aβ-lipid interactions. J. Biol. Chem. 276, 33561-33356.
33. McLaurin, J., Franklin, T., Chakrabartty, A. & Fraser, P.E. (1998) Phosphatidylinositol and inositol involvement in Alzheimer amyloid-β fibril growth and arrest. J. Mol. Biol. 278, 183-194.
34. Van Blitterswijk, WJ., Hoeven, R.P. & Van Der Meer, B.W. (1981) Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim. Biophys. Acta 644, 323-332.
35. Parasassi, T., DeStasio, C., Ravagnan, G., Rusch, R.M. & Gratton, E. (1991) Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of laurdan fluorescence. Biophys. J. 60, 179-189.
36. Luzardo, M.D.C., Bernik, D.L., Pazos, I.F., Figueroa, S., Lanio, M.E., Verez, V. & Disalvo, E.A. (1999) Phase and surface properties of lipid bilayers containing neoglycolipids. Arch. Biochem. Biophys. 363, 81-90.
37. Bernik, D.L. & Disalvo, E.A. (1996) Gel state surface properties of phosphatidylcholine liposomes as measured with merocyanine 540. Chem. Phys Lipids 82, 111-123.
38. Narayanan, V. & Scarlata, S. (2001) Membrane binding and self association of α-synuclein. Biochemistry 40, 9927-9934.
39. Lee, H.-J., Choi, C. & Lee, S.-J. (2002) Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671-678.
40. Yip, C.M. & McLaurin, J. (2001) Amyloid-β peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 80, 1359-1371.
41. Ji, S.R., Wu, Y. & Sui, S.F. (2002) Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (Aβ1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277, 6273-6279.
42. Conway, K.A., Harper, J.D. & Lansbury, P.T. (1998) Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 2552-2563.
43. Giasson, B.I., Uryu, K., Trojanowski, J.Q. & Lee, V.M.-Y. (1999) Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274, 7619-7622.
44. Sharon, R., Bar-Joseph, I., Mirick, G.E., Serhan, C.N. & Selkoe, D.J. (2003) Altered fatty acid composition of Dopaminergic neurons expressing α-synuclein and human brains with α-synucleinopathies. J. Biol. Chem. 278, 49874-49881.
45. Bussell, R. & Eliezer, D. (2001) Residual structure and dynamics in Parkinson's disease-associated mutants of α-synuclein. J. Biol. Chem. 276, 45996-46003.
46. Bagatolli, L.A., Parasassi, T., Fidelio, G.D. & Gratton, E. (1990) A Model for the interaction of 6-laurolyl-2-(N,N-dimethylamino) naphthalene with lipid environments: implications for spectral properties. Photochem. Photobiol. 70, 557-564.
47. Bussell, R. & Eliezer, D. (2003) A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins. J. Mol. Biol. 329, 763-778.
48. Gai, W.P., Yuan, H.X., Li, X.Q., Power, J.T.H., Blumbers, P.C. & Jensen, P.H. (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166, 324-333.
49. Zhu, M. & Fink, A.L. (2003) Lipid binding inhibits α-synuclein fibril formation. J. Biol. Chem. 278, 16873-16877.
50. Conway, K.A., Harper, J.D. & Lansbury, P.T. (1998) Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nature Med. 4, 1318-1320.
51. Conway, K.A., Harper, J.D. & Lansbury, P.T. Jr (2000) Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 2552-2563.
52. Narhi, L., Wood, S.J., Steavenson, S., Jiang, Y., Wu, G.M., Anafi, D. et al. (1999) Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843-9846.
53. Yang, D.S., Yip, C.M., Huang, T.H., Chakrabartty, A. & Fraser, P.E. (1999) Manipulating the amyloid-aggregation pathway with chemical chaperone. J. Biol. Chem. 274, 32970-32974.
54. Shtilerman, M.D., Ding, T.T. & Lansbury, P.T. (2002) Molecular crowding accelerates fibrillization of α-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41, 3855-3860.